U.S. patent application number 16/004554 was filed with the patent office on 2018-10-11 for reduced-pressure, wound-closure and treatment systems and methods.
The applicant listed for this patent is KCI Licensing, Inc.. Invention is credited to Christopher Guy COWARD, Colin John HALL, Ian James HARDMAN, Keith Patrick HEATON.
Application Number | 20180289558 16/004554 |
Document ID | / |
Family ID | 40852212 |
Filed Date | 2018-10-11 |
United States Patent
Application |
20180289558 |
Kind Code |
A1 |
HEATON; Keith Patrick ; et
al. |
October 11, 2018 |
Reduced-Pressure, Wound-Closure And Treatment Systems And
Methods
Abstract
A reduced-pressure, wound closure system is presented that
generates a closing force on a surface wound and optionally
provides reduced pressure to a body cavity or tissue site. The
sealed contracting member, when placed under reduced pressure,
generates the closing force. One illustrative system includes a
first attachment member and a second attachment member, a sealed
contracting member coupled to the first attachment member and the
second attachment member, and wherein the closing force is
generated between the first attachment member and the second
attachment member when reduced pressure is supplied to the sealed
contracting member. Other systems and methods are presented.
Inventors: |
HEATON; Keith Patrick;
(Poole, GB) ; HARDMAN; Ian James; (Bournemouth,
GB) ; COWARD; Christopher Guy; (Wareham, GB) ;
HALL; Colin John; (Poole, GB) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
KCI Licensing, Inc. |
San Antonio |
TX |
US |
|
|
Family ID: |
40852212 |
Appl. No.: |
16/004554 |
Filed: |
June 11, 2018 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
15042367 |
Feb 12, 2016 |
10016307 |
|
|
16004554 |
|
|
|
|
13401502 |
Feb 21, 2012 |
9289326 |
|
|
15042367 |
|
|
|
|
12467203 |
May 15, 2009 |
8142419 |
|
|
13401502 |
|
|
|
|
61109390 |
Oct 29, 2008 |
|
|
|
61109410 |
Oct 29, 2008 |
|
|
|
61109448 |
Oct 29, 2008 |
|
|
|
61109486 |
Oct 29, 2008 |
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61B 2017/00646
20130101; Y10T 156/1056 20150115; Y10T 29/49826 20150115; A61M
1/0092 20140204; A61F 13/00038 20130101; Y10T 156/1304 20150115;
Y10T 156/1052 20150115; A61M 2210/1021 20130101; A61F 13/00025
20130101; A61B 2017/00575 20130101; Y10T 29/49 20150115; Y10T
156/1057 20150115; A61F 13/00068 20130101; A61F 13/00987 20130101;
Y10T 156/1062 20150115; A61F 13/00029 20130101; A61B 17/0057
20130101; A61M 1/0088 20130101; A61F 13/00034 20130101; A61B
2017/00676 20130101 |
International
Class: |
A61F 13/00 20060101
A61F013/00; A61M 1/00 20060101 A61M001/00; A61B 17/00 20060101
A61B017/00 |
Claims
1-21. (canceled)
22. A method of manufacturing a reduced-pressure, wound-closure
system for providing a closing force to a surface wound on a
patient, the method comprising the steps of: forming a first
attachment member for releasably attaching to a first portion of
the patient's epidermis proximate an edge of the surface wound;
forming a second attachment member for releasably attaching to a
second portion of the patient's epidermis proximate the edge of the
surface wound; and forming a sealed contracting member operable to
contract under reduced pressure; forming a reduced-pressure
interface.
23. The method of manufacturing of claim 22 further comprising
coupling the sealed contracting member to the first attachment
member and the second attachment member.
24. The method of manufacturing of claim 22 further comprising the
step of fluidly coupling the reduced-pressure interface to the
sealed contracting member.
25. The method of manufacturing of claim 22 further comprising
forming a circumferential wall and coupling the circumferential
wall to the first attachment member and the second attachment
member.
26. The method of manufacturing of claim 25 wherein the step of
coupling the sealed contracting member to the first attachment
member and the second attachment member comprises the step of
coupling the sealed contracting member to at least a portion of the
circumferential wall.
27. (canceled)
28. A reduced-pressure, wound-closure system for providing a
closing force to a surface wound on a patient, the
reduced-pressure, wound-closure system comprising: a sealing member
for releasably attaching to a first portion of the patient's
epidermis proximate an edge of the surface wound; a first
attachment member attached to the sealing member; a second
attachment member attached to the sealing member, wherein the first
attachment member is spaced from the second attachment member; a
sealed contracting member coupled to the first attachment member
and the second attachment member and configured to contract under
reduced pressure, the sealed contracting member comprising a
contracting manifold that is pneumatically sealed from the surface
wound; and wherein a closing force is developed between the first
attachment member and the second attachment member when reduced
pressure is supplied to the sealed contracting member.
29. The reduced-pressure, wound-closure system of claim 28 further
comprising a reduced-pressure interface coupled to the first
attachment member.
30. The reduced-pressure, wound-closure system of claim 28 wherein:
the first attachment member comprises a first base member and a
first adhesive; and the second attachment member comprises a second
base member and a second adhesive.
31. The reduced-pressure, wound-closure system of claim 30 further
comprising a wall member coupled to the first base member and a
reduced-pressure interface coupled to the wall member.
32. The reduced-pressure, wound-closure system of claim 28 wherein
the first attachment member comprises: a first base member having a
first side and a second, inward-facing side; a first wall coupled
to the first base member; and a first adhesive coupled to the
second, inward-facing side of the first base member.
33. A reduced-pressure, wound-closure and treatment system for
providing a closing force to a surface wound on a patient and for
delivering reduced pressure to a tissue site, the reduced-pressure,
wound-closure and treatment system comprising: a wound-closing
subsystem comprising: a first attachment member for releasably
attaching to a first portion of the patient's epidermis proximate
an edge of the surface wound, a second attachment member for
releasably attaching to a second portion of the patient's epidermis
proximate the edge of the surface wound, wherein the first
attachment member is spaced from the second attachment member, a
sealed contracting member coupled to the first attachment member
and the second attachment member and configured to contract under
reduced pressure, the sealed contracting member comprising a
contracting manifold that is pneumatically sealed from the surface
wound; a reduced-pressure treatment subsystem comprising: a
manifold for disposing proximate the tissue site, the manifold
configured to distribute reduced pressure and to receive fluids, a
sealing member for placement on the patient's epidermis and
configured to form a pneumatic seal over the manifold; a
reduced-pressure connector configured to fluidly couple the sealed
contracting member and the manifold; and a reduced-pressure source
operable to deliver a closing reduced pressure to the sealed
contracting member and a treatment reduced pressure to the
manifold, wherein a closing force is developed between the first
attachment member and the second attachment member when the closing
reduced pressure is supplied to the sealed contracting member.
34. The reduced-pressure, wound-closure and treatment system of
claim 33 wherein the reduced-pressure source comprises a first
reduced-pressure source and a second reduced-pressure source, and
wherein: the first reduced-pressure source is configured to deliver
the closing reduced pressure; and the second reduced-pressure
source is configured to deliver the treatment reduced pressure.
35. The reduced-pressure, wound-closure and treatment system of
claim 33 wherein the reduced-pressure source comprises: a
reduced-pressure unit; a reduced-pressure interface; a
reduced-pressure delivery conduit configured to fluidly couple the
reduced-pressure unit and the reduced-pressure interface; and
wherein the reduced-pressure interface is configured to fluidly
couple to the manifold.
36. The reduced-pressure, wound-closure and treatment system of
claim 35 wherein when reduced pressure is delivered from the
reduced-pressure interface to the manifold, the reduced pressure is
also delivered through the reduced-pressure connector to the sealed
contracting member.
37. The reduced-pressure, wound-closure and treatment system of
claim 33 wherein the reduced-pressure source comprises: a
reduced-pressure unit; a reduced-pressure interface; a
reduced-pressure delivery conduit operable to fluidly couple the
reduced-pressure unit and the reduced-pressure interface; wherein
the reduced-pressure interface is configured to fluidly couple to
the sealed contracting member.
38. The reduced-pressure, wound-closure and treatment system of
claim 37 wherein when reduced pressure is delivered from the
reduced-pressure interface to the sealed contracting member, the
reduced pressure is also delivered through the reduced-pressure
connector to the manifold.
39. A reduced-pressure, wound-closure system for providing a
closing force to a surface wound on a patient, the
reduced-pressure, wound-closure system comprising: a plurality of
attachment members for releasably attaching to the patient's
epidermis proximate an edge of the surface wound, wherein each of
the plurality of attachment members further comprises an attachment
device; a circumferential wall coupled to the plurality of
attachment members, the circumferential wall for disposing
proximate the surface wound; a sealed contracting member
pneumatically isolated from the surface wound, the sealed
contracting member coupled to at least a portion of the
circumferential wall, wherein the sealed contracting member extends
in a first direction away from the surface wound and extends in a
second direction within the circumferential wall along the surface
wound, wherein the sealed contracting member is configured to
contract under reduced pressure to move the circumferential wall,
and wherein the sealed contracting member is configured to contract
more in the second direction than in the first direction under
reduced pressure; and wherein a closing force is developed when
reduced pressure is supplied to the sealed contracting member.
40. The reduced-pressure, wound-closure system of claim 39 wherein
the circumferential wall comprises polypropylene.
41. The reduced-pressure, wound-closure system of claim 39 wherein
the circumferential wall comprises rigid silicone.
42. The reduced-pressure, wound-closure system of claim 39 wherein
each attachment member of the plurality of attachment members
comprises a first base member and the attachment device comprises
adhesive.
43. The reduced-pressure, wound-closure system of claim 39 wherein
each of the plurality of attachment members comprises: a first base
member having a first side and a second, inward-facing side; a
first wall coupled to the first base member; and wherein the
attachment device comprises an adhesive that is coupled to the
second, inward-facing side of the first base member.
44. The reduced-pressure, wound-closure system of claim 39 wherein
the sealed contracting member comprises: a contracting manifold
material having a first side and a second, inward-facing side, and
a peripheral edge; a first sealing member disposed proximate the
first side of the contracting manifold material; a second sealing
member disposed proximate the second, inward-facing side of the
contracting manifold material; a peripheral sealing member disposed
proximate the peripheral edge of the contracting manifold material;
and wherein the first sealing member, second sealing member, and
peripheral sealing member are configured to pneumatically seal the
contracting manifold material.
45. The reduced-pressure, wound-closure system of claim 44 wherein
the peripheral sealing member comprises a third sealing member.
46. The reduced-pressure, wound-closure system of claim 44 wherein
the peripheral sealing member comprises a wall.
Description
RELATED APPLICATIONS
[0001] The present application is a continuation of U.S. patent
application Ser. No. 15/042,367, entitled "Reduced-Pressure,
Wound-Closure and Treatment Systems and Methods," filed on Feb. 12,
2016, which is a divisional of U.S. patent application Ser. No.
13/401,502, entitled "Reduced-Pressure, Wound-Closure and Treatment
Systems and Methods," filed on Feb. 21, 2012, now U.S. Pat. No.
9,289,326 which is a divisional of U.S. patent application Ser. No.
12/467,203, entitled "Reduced-Pressure, Wound-Closure and Treatment
Systems and Methods," filed on May 15, 2009, now U.S. Pat. No.
8,142,419 which claims the benefit, under 35 USC .sctn. 119(e), of
the filing of U.S. Provisional Patent Application Ser. No.
61/109,410, entitled "Reduced-Pressure, Wound-Closure System and
Method," filed Oct. 29, 2008; U.S. Provisional Patent Application
Ser. No. 61/109,486, entitled "Reduced-Pressure, Abdominal
Treatment System and Method," filed Oct. 29, 2008; U.S. Provisional
Patent Application Ser. No. 61/109,390, entitled "Open-Cavity,
Reduced-Pressure Wound Dressing and System," filed Oct. 29, 2008;
and U.S. Provisional Patent Application Ser. No. 61/109,448,
entitled "Reduced-Pressure, Deep-Tissue Closure System and Method,"
filed Oct. 29, 2008. All of these applications are incorporated
herein by reference for all purposes.
BACKGROUND
[0002] The present invention relates generally to medical treatment
systems and, more particularly, to reduced-pressure, wound-closure
and treatment systems and methods.
[0003] Whether the etiology of a wound, or damaged area of tissue,
is trauma, surgery, or another cause, proper care of the wound is
important to the outcome. Unique challenges exist when the wound
involves locations that require reentry, such as the peritoneal
cavity and more generally the abdominal cavity. Many times when
surgery or trauma involves the abdominal cavity, establishing a
wound management system that facilitates reentry allows for better
and easier care and helps to address such things as peritonitis,
abdominal compartment syndrome (ACS), and infections that might
inhibit final healing of the wound and the internal organs. In
providing such care, it may be desirable to remove unwanted fluids
from the cavity, help approximate the fascia and other tissues, or
finally to help provide a closing force on the wound itself at the
level of the epidermis. Unless otherwise indicated, as used herein,
"or" does not require mutual exclusivity.
[0004] Currently, an abdominal opening on the epidermis may be
closed using sutures, staples, clips, and other mechanical devices
to allow the skin to be held and pulled. Such devices often cause
puncture wounds or can cause other wounds. If severe edema occurs,
tremendous pressure may be placed on the closure device and the
pressure may cause harm. For example, if the pressure rises due to
edema, the sutures may tear out.
[0005] With respect to an overall system for allowing reentry into
the abdominal cavity, a number of techniques have been developed.
One approach is to place towels into the cavity and then use clips,
such as hemostats, to close the skin over the towels. While simple
and fast, the results are regarded as suboptimal. Another approach
is the so-called "Bogota bag." With this approach, a bag is sutured
into place to cover the open abdomen in order to provide a barrier.
Still another approach, sometimes called a "vac pack," is to pack
towels in the wound and then place a drain into the abdomen and
cover the abdomen with a drape. Finally, a reduced pressure
approach has been used. Such an approach is shown in U.S. Pat. No.
7,381,859 to Hunt et al. and assigned to KCI Licensing, Inc. of San
Antonio, Tex. U.S. Pat. No. 7,381,859 is incorporated herein by
reference for all purposes.
SUMMARY
[0006] Problems with existing wound closure devices and
reduced-pressure treatment systems are addressed by the systems,
apparatus, and methods of the illustrative embodiments described
herein. According to one illustrative embodiment, a
reduced-pressure, wound-closure system for providing a closing
force to a surface wound on a patient includes a first attachment
member for releasably attaching to a first portion of the patient's
epidermis proximate an edge of the surface wound and a second
attachment member for releasably attaching to a second portion of
the patient's epidermis proximate the edge of the surface wound.
The first attachment member is spaced from the second attachment
member. The reduced-pressure, wound-closure system further includes
a sealed contracting member coupled to the first attachment member
and the second attachment member and operable to contract when
placed under reduced pressure. The reduced-pressure, wound-closure
system is operable to develop a closing force between the first
attachment member and the second attachment member when reduced
pressure is supplied to the sealed contracting member.
[0007] According to another illustrative embodiment, a
reduced-pressure, wound-closure system for providing a closing
force to a surface wound on a patient includes a first attachment
member for releasably attaching to a first portion of the patient's
epidermis proximate an edge of the surface wound and a second
attachment member for releasably attaching to a second portion of
the patient's epidermis proximate the edge of the surface wound.
The first attachment member is spaced from the second attachment
member. The reduced-pressure, wound-closure system further includes
a circumferential wall that is coupled to the first attachment
member and the second attachment member. The reduced-pressure,
wound-closure system further includes a sealed contracting member
coupled to at least a portion of the circumferential wall and
operable to contract when placed under reduced pressure. A
reduced-pressure source is fluidly coupled to the sealed
contracting member and is operable to deliver a reduced pressure to
the sealed contracting member. A closing force is developed when
reduced pressure is supplied by the reduced-pressure source to the
sealed contracting member.
[0008] According to another illustrative embodiment, a
reduced-pressure, wound-closure and treatment system for providing
a closing force to a surface wound on a patient and for delivering
reduced pressure to tissue site includes a wound-closing subsystem
and a reduced-pressure treatment subsystem.
[0009] According to another illustrative embodiment, a method of
manufacturing a reduced-pressure, wound-closure system for
providing a closing force to a surface wound on a patient includes
the steps of: forming a first attachment member for releasably
attaching to a first portion of the patient's epidermis proximate
an edge of the surface wound and forming a second attachment member
for releasably attaching to a second portion of the patient's
epidermis proximate the edge of the surface wound. The method of
manufacturing a reduced-pressure, wound-closure system further
includes forming a sealed contracting member operable to contract
when placed under reduced pressure and coupling the sealed
contracting member to the first attachment member and the second
attachment member.
[0010] According to another illustrative embodiment, a method for
providing a closing force to a surface wound on a patient includes
the steps of releasably attaching a first attachment member to a
first portion of the patient's epidermis proximate an edge of the
surface wound and releasably attaching a second attachment member
to a second portion of the patient's epidermis proximate the edge
of the surface wound. The first attachment member is spaced from
the second attachment member. The method of providing a closing
force further includes providing a sealed contracting member and
fluidly coupling the sealed contracting member to the first
attachment member and the second attachment member. The sealed
contracting member is operable to contract when placed under
reduced pressure. The method of providing a closing force further
includes supplying a reduced pressure to the sealed contracting
member, whereby a closing force is developed between the first
attachment member and the second attachment member.
[0011] Other objects, features, and advantages of the illustrative
embodiments will become apparent with reference to the drawings and
detailed description that follow.
BRIEF DESCRIPTION OF THE DRAWINGS
[0012] FIG. 1 is a schematic cross-section, with a portion
presented as a block diagram, of an illustrative embodiment of a
reduced-pressure, wound-closure and treatment system;
[0013] FIG. 2 is a schematic, cross-sectional view of a portion of
the reduced-pressure, wound closure and treatment system of FIG.
1;
[0014] FIG. 3A is a schematic, perspective view of an illustrative
embodiment of a portion of a reduced-pressure, wound-closure
system;
[0015] FIGS. 3B and 3C are schematic, plan views of the
illustrative embodiment of FIG. 3A shown in a non-contracted
position (FIG. 3B) and a contracted position (FIG. 3C);
[0016] FIG. 4A is a schematic, perspective view of a
reduced-pressure connector;
[0017] FIG. 4B is an elevational view of the reduced-pressure
connector of FIG. 4A;
[0018] FIG. 5A is a schematic, cross-sectional view of a portion of
another illustrative embodiment of a reduced-pressure,
wound-closure and treatment system; and
[0019] FIG. 5B is a schematic, cross-sectional view of a portion of
another illustrative embodiment of a reduced-pressure,
wound-closure and treatment system.
DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
[0020] In the following detailed description of the illustrative
embodiments, reference is made to the accompanying drawings that
form a part hereof. These embodiments are described in sufficient
detail to enable those skilled in the art to practice the
invention, and it is understood that other embodiments may be
utilized and that logical structural, mechanical, electrical, and
chemical changes may be made without departing from the spirit or
scope of the invention. To avoid detail not necessary to enable
those skilled in the art to practice the embodiments described
herein, the description may omit certain information known to those
skilled in the art. The following detailed description is,
therefore, not to be taken in a limiting sense, and the scope of
the illustrative embodiments are defined only by the appended
claims.
[0021] Referring to FIGS. 1-2, and initially to FIG. 1, an
illustrative embodiment of a reduced-pressure, wound-closure and
treatment system 100 is presented. The reduced-pressure,
wound-closure and treatment system 100 may include a
reduced-pressure treatment subsystem 102 and a wound-closure
subsystem 104. The reduced-pressure treatment subsystem 102 may be
used for treating a tissue site 106 with reduced pressure. The
tissue site 106 may be the bodily tissue of any human, animal, or
other organism, including bone tissue, adipose tissue, muscle
tissue, dermal tissue, vascular tissue, connective tissue,
cartilage, tendons, ligaments, or any other tissue. The tissue site
106 may be within a body cavity, such as an abdominal cavity 110,
and may include various tissue layers including a wound in
epidermis 108. Treatment with the reduced-pressure treatment
subsystem 102 may include removing fluids, such as ascites or
exudates, delivering reduced pressure, or providing a protective
barrier.
[0022] In the illustrative embodiment, the reduced-pressure,
wound-closure and treatment system 100 is presented in the context
of the abdominal cavity 110 and a surface wound 111, which has
wound edges 112. Other subdermal tissue 114 may also have been
opened, such as fat tissue, muscles, fascia, etc. The abdominal
cavity 110 is shown with abdominal contents 116, which form a
surface or support.
[0023] The reduced-pressure treatment subsystem 102 of the
reduced-pressure, wound-closure and treatment system 100 helps to
deliver reduced pressure to the tissue site 106 and the abdominal
cavity 110. The reduced-pressure treatment subsystem 102 includes a
manifold 118 disposed within the abdominal cavity 110 to distribute
reduced pressure within the abdominal cavity 110 and to receive
fluids. The manifold 118 may include or be associated with a
manifold member 120, or second manifold, in a non-adherent envelope
122. The non-adherent envelope 122 has apertures 124 on a first
side and apertures 126 on a second, inward-facing (or
tissue-facing) side. The apertures 124 and 126 facilitate flow of
fluids as suggested by arrows 128. The apertures 124 and 126 may
take any shape, such as rectangular openings, circular openings,
polygons, slits (elongated slots), etc. The non-adherent envelope
122 may be formed from a flexible film, such as a polyurethane
film, a drape material, or any non-adherent material.
[0024] Reduced pressure may be applied by the reduced-pressure
treatment subsystem 102 to the abdominal cavity 110 and the tissue
site 106 to help promote removal of exudates, ascites, or other
liquids, bacteria, fibrin, dead tissue, toxins, residual blood,
etc. Reduced pressure may also be used in certain situations to
stimulate growth of additional tissue. In the case of a wound at
the tissue site 106, the growth of granulation tissue and removal
of exudates and bacteria may help to promote healing of the wound.
In the situation of a non-wounded or non-defective tissue, reduced
pressure may be used to promote the growth of tissue that may be
harvested and transplanted to another tissue site. In other
situations, fluid removal may be the main reason for applying
reduced pressure.
[0025] As used herein, "reduced pressure" generally refers to a
pressure less than the ambient pressure at the tissue site 106. In
most cases, the reduced pressure will be less than atmospheric
pressure at which the patient is located. Alternatively, the
reduced pressure may be less than the hydrostatic pressure of the
tissue site 106. Unless otherwise indicated, values of pressure
stated herein are gauge pressures.
[0026] The manifold 118 and the manifold member 120 are disposed in
the abdominal cavity 110 and may be disposed at or near the tissue
site 106. Typically, the non-adherent envelope 122, which contains
the manifold member 120, is disposed against the tissue site 106
and, in particular, proximate the abdominal contents 116. The
manifold 118 is disposed adjacent the non-adherent envelope 122.
The manifold 118 and the manifold member 120 may take many forms.
The term "manifold" as used herein generally refers to a substance
or structure that is provided to assist in applying reduced
pressure to, delivering fluids to, or removing fluids from a tissue
site, such as the tissue site 106. The manifold 118 and the
manifold member 120 typically include a plurality of flow channels
or pathways that are interconnected to improve distribution of
fluids provided to and removed from the area proximate the manifold
118 and the manifold member 120. The manifold 118 and the manifold
member 120 may be formed from a biocompatible material that is
capable of being placed in contact with tissue and that distributes
reduced pressure. Examples of manifolds may include, without
limitation, devices that have structural elements arranged to form
flow channels, cellular foam, such as open-cell foam, porous tissue
collections, and liquids, gels and foams that include or cure to
include flow channels.
[0027] The manifold 118 and the manifold member 120 may be porous
and may be made from foam, gauze, felted mat, or any other material
suited to a particular biological application. In one embodiment,
the manifold 118 and the manifold member 120 are made from a porous
foam that includes a plurality of interconnected cells or pores
that act as flow channels. The porous foam may be a polyurethane,
open-cell, reticulated foam, such as a GranuFoam.RTM. material
manufactured by Kinetic Concepts, Incorporated of San Antonio, Tex.
Other embodiments may include "closed cells" at certain locations
to help direct flow. In some situations, the manifold 118, the
manifold member 120, and the non-adherent envelope 122 may be used
to distribute fluids, such as medications, antibacterials, growth
factors, and other solutions to the tissue site 106. Other layers
may be included as part of the manifold 118 or the manifold member
120, such as absorptive material, wicking material, hydrophobic
material, and hydrophilic material.
[0028] A sealing member 132 may be placed over the surface wound
111 in the epidermis 108 and, in particular, made to overlap the
wound edges 112 to provide a pneumatic seal. Thus, the sealing
member 132 provides a seal over the manifold 118 and the
non-adherent envelope 122. The sealing member 132 may be a cover
that is used to secure the manifold 118 and non-adherent envelope
122 at the tissue site 106. While the sealing member 132 may be
impermeable or semi-permeable, the sealing member 132 is capable of
maintaining a reduced pressure at the tissue site 106 after
installation of the sealing member 132 over the manifold 118. The
sealing member 132 may be a flexible over-drape or film formed from
a silicone based compound, acrylic, hydrogel or hydrogel-forming
material, or any other biocompatible material that includes the
impermeability or permeability characteristics desired for the
intended tissue site.
[0029] The sealing member 132 may further include an attachment
device 136 to secure the sealing member 132 to the patient's
epidermis 108. The attachment device 136 may take many forms; for
example, a sealing tape might be used or an adhesive 134 may be
positioned along a perimeter of the sealing member 132 or any
portion of the sealing member 132 to provide a pneumatic seal. The
adhesive 134 might also be pre-applied and covered with a
releasable member (not shown) that is removed at the time of
application.
[0030] A first reduced-pressure interface 138, such as a port 140,
or connector, may be used to deliver reduced pressure from a first
reduced-pressure delivery conduit 142 to the manifold 118 to the
reduced-pressure delivery conduit 142. The first reduced-pressure
interface 138 may also deliver any exudate, ascites, or other
fluids from the manifold 118 to the reduced-pressure delivery
conduit 142. The reduced pressure in the manifold 118 pulls the
fluid in the direction shown by arrows 144 and to the first
reduced-pressure delivery conduit 142. The first reduced-pressure
interface 138 permits the passage of fluid from the manifold 118 to
the first reduced-pressure delivery conduit 142. For example,
fluids collected from the tissue site 106 using the manifold member
120 may enter the first reduced-pressure delivery conduit 142 via
the first reduced-pressure interface 138. In another embodiment,
the reduced-pressure treatment subsystem 102 may exclude the first
reduced-pressure interface 138, and the first reduced-pressure
delivery conduit 142 may be inserted directly into the sealing
member 132 and the manifold 118. The first reduced-pressure
delivery conduit 142 may be a medical conduit, multi-lumen member,
tubing, or any other means for delivering a reduced pressure.
[0031] A reduced-pressure subsystem 148 may be used to supply the
reduced pressure that is delivered to the first reduced-pressure
delivery conduit 142. The reduced-pressure subsystem 148 may
include a first reduced-pressure unit, or source, 150 that delivers
reduced pressure to a supply conduit 152, which delivers the
reduced pressure to a three-way valve 154. One portion of the
reduced pressure may leave the three-way valve 154 through a second
reduced-pressure delivery conduit 156. Another portion of the
reduced pressure may leave the three-way valve 154 through a
reduced-pressure conduit 158. Located on the reduced-pressure
conduit 158 may be any number of devices, such as a
reduced-pressure feedback unit 160, which may, for example, give
feedback to the three-way valve 154 concerning the regulation of
the reduced pressure within the reduced-pressure conduit 158. The
reduced-pressure conduit 158 delivers the reduced pressure to a
canister 162, which is operable to hold any fluids delivered to the
canister 162 from the tissue site 106. Reduced pressure leaving the
canister 162 is delivered to the first reduced-pressure delivery
conduit 142. The first reduced-pressure delivery conduit 142 may be
referred to as delivering a second reduced pressure, or treatment
reduced pressure. The second reduced pressure, or treatment reduced
pressure, has been placed, by the reduced-pressure subsystem 148,
at the desired pressure and conditions for use in reduced-pressure
treatment at the tissue site 106.
[0032] A number of different devices, e.g., representative device
166, may be added to a medial portion 164 of the first
reduced-pressure delivery conduit 142. The reduced pressure
delivered to the first reduced-pressure delivery conduit 142 is
typically selected to be in the range of -50 mm Hg to -500 mm Hg
and more typically in the range -100 mm Hg to -300 mm Hg. The
device 166 might be a pressure feedback device, a volume detection
system, a blood detection system, an infection detection system, a
flow monitoring system, a temperature monitoring system, etc. Some
of these devices may be formed integrally with other parts; for
example, the canister 162 may include one or more filters, e.g., a
hydrophobic filter that prevents liquid from exiting.
[0033] There are many ways of developing the reduced pressure to be
used with the reduced-pressure, wound-closure and treatment system
100. In the illustrative embodiment shown, the first
reduced-pressure unit 150 is used for both applications, i.e., for
wound closing and for reduced-pressure treatment. In an alternative
embodiment, it may be desirable to use the first reduced-pressure
unit 150 as the source for the second reduced-pressure delivery
conduit 156 and have a second reduced-pressure unit 151 (shown in
broken lines) to deliver reduced pressure to the reduced-pressure
conduit 158.
[0034] As an aspect of the reduced-pressure, wound-closure and
treatment system 100, it is also desirable to help provide a
closing force to the surface wound 111 and, in particular, to apply
a closing force between the wound edges 112. As shown in FIGS. 1
and 2, the wound-closure subsystem 104 may be used for this
purpose. The wound-closure subsystem 104 develops a closing force
represented by arrows 170. The closing force is communicated to the
patient's epidermis 108 and urges the wound edges 112 towards each
other. The wound-closure subsystem 104 may be a stand alone system
for closing any surface wound or used as part of a larger system,
e.g., the reduced-pressure, wound-closure and treatment system
100.
[0035] The wound-closure subsystem 104 may include a plurality of
attachment members, e.g., a first attachment member 172 and a
second attachments member 184, that are spaced around and proximate
the wound edges 112 of the surface wound 111. The first attachment
member 172 has a first base member 174 and a first wall member 176.
The first base member 174 has a first side 178 and a second,
inward-facing (patient-facing) side 180. The first base member 174
and first wall member 176 may be made from numerous materials, but
a material is preferred that provides some flexibility; for
example, the first attachment member 172 may be formed with the
first base member 174 and the first wall member 176 made from
polypropylene, or a rigid silicone, etc. A first adhesive 182 or
other attachment device may be applied to the second, inward-facing
(patient-facing) side 180 of first base member 174 to allow the
first base member 174 to be releasably attached directly to a
portion of the patient's epidermis 108 or indirectly if a
polyurethane film or other sealing member 132 is placed on the
epidermis 108 first. In addition to the adhesive 182, cement,
staples, or sutures, or other invasive or non-invasive approaches
might be used to attach the first base member 174 to intact
epidermis tissue. The first attachment member 172 may be applied
directly on top of the epidermis 108 or on top of the sealing
member 132 so that whatever forces are applied on the first
attachment member 172 are transmitted directly, or indirectly, to
the epidermis 108. References to applying the attachment member 172
to the epidermis 108 should be deemed to include application on top
of the sealing member 132.
[0036] Almost directly across the surface wound 111, e.g.,
epidermis wound, from the first attachment member 172 is the second
attachment member 184. The second attachment member 184 is
analogous to the first attachment member 172. While the
wound-closure subsystem 104 only shows two attachment members 172,
184, other attachment members may be dispersed around the surface
wound 111 in a spaced fashion. The two attachment members 172, 184
in conjunction with a sealed contracting member 188 allow the
closing force, which is represented by arrows 170, to be developed,
but additional attachment members allow forces to be developed
radially across different shapes of the surface wound 111.
[0037] One or more of the attachment members, e.g., attachment
member 172, has a reduced-pressure interface for receiving reduced
pressure from the second reduced-pressure delivery conduit 156. For
example, as shown clearly in FIG. 2, the first attachment member
172 may include a second reduced-pressure interface 183. The
reduced pressure delivered through the second reduced-pressure
interface 183 is used to develop the closing force.
[0038] The wound-closure subsystem 104 includes the sealed
contracting member 188 to develop the closing force. The sealed
contracting member 188 may be formed from a contracting manifold
material, or member, which may be the same type of material as the
manifold 118. Alternatively, it may be desirable to use a
contracting manifold material that has fewer apertures or holes
than the material used for the manifold 118 or a pneumatic device.
In addition, it may be desirable to have a material that will
contract less in the vertical (for the orientation shown in FIG. 1)
and more in the horizontal, or lateral, plane (for the orientation
shown in FIG. 1). The sealed contracting member 188 has a first
side 190 and a second, inward-facing (patient-facing) side 192. The
sealed contracting member 188 also has a peripheral edge 194. The
sealed contracting member 188 may be sealed by having a first
sealing member 196 (FIG. 2) applied to the first side 190 and a
second sealing member 198 applied to the second, inward-facing side
192 of the sealed contracting member 188 and sealing the peripheral
edges 194.
[0039] The peripheral edge 194 of the sealed contracting member 188
may be sealed by a peripheral sealing member 200. Alternatively or
in addition, the first wall member 176 may also be used as the
peripheral sealing member to seal the peripheral edge 194 or
another piece of sealed material may be used. Similarly, the
second, inward-facing side 192 may be sealed by placement against
the sealing member 132 or the patient's epidermis 108. The sealed
contracting member 188 may also be sealed by being coated with a
gas-impervious material. The sealed contracting member 188 may be
sealed with the first and second sealing members 196, 198, which
may be formed from a polyurethane film or silicone. The first and
second sealing members 196, 198 may be ultrasonically welded, or RF
welded, or otherwise coupled at their ends to cover the peripheral
edge 194. When reduced pressure is supplied to the sealed
contracting member 188, the sealed contracting member 188 contracts
to develop a closing force, which is represented by arrows 170.
[0040] The sealed contracting member 188 may be formed with an
opening 201 on a portion of the sealed contracting member 188 for
receiving an extension portion 202 of the first reduced-pressure
interface 138. The extension portion 202 may extend through the
sealed contracting member 188 and into the manifold 118. In an
alternative embodiment, the second reduced-pressure interface 183
and the second reduced-pressure delivery conduit 156 may be omitted
and a portion of the first reduced-pressure interface 138 fluidly
coupled to the sealed contracting member 188. Thus, in this
alternative embodiment, a single reduced-pressure source and
conduit may be used for both providing a closing force and for the
reduced-pressure treatment. The same is true of the illustrative
embodiments of FIGS. 5A and 5B.
[0041] In operation, the reduced-pressure wound-closure and
treatment system 100 may be used in a body cavity, e.g., the
abdominal cavity 110, by first applying a manifold material on the
abdominal contents 116. For example, the manifold member 120 with
the non-adherent envelope 122 may be placed on the abdominal
contents 116 and the manifold 118 disposed proximate the
non-adherent envelope 122. The wound edges 112 of the surface wound
111 may be brought together to the extent possible, and then the
sealing member 132 placed onto the epidermis 108 to provide a
pneumatic seal over the surface wound 111. The first attachment
member 172 may be applied using the first adhesive 182 to the
patient's epidermis 108 (or on sealing member 132 as shown)
proximate the wound edge 112. Similarly, the second attachment
member 184 may be applied proximate the wound edge 112 on the
opposite side. Either before the first and second attachment
members 172 and 184 are applied to the epidermis 108, or
afterwards, the sealed contracting member 188 is coupled to the
first and second attachment members 172 and 184. This coupling may
be accomplished in a number of different ways, such as by using
adhesives 189 and 191, cements, bonding, etc. The first
reduced-pressure interface 138, which may be the reduced-pressure
port 140, may be applied such that an extension portion 202 reaches
into the manifold 118. The first reduced-pressure delivery conduit
142 may be fluidly coupled to the first reduced-pressure interface
138 and fluidly coupled to the first reduced-pressure unit 150 (or
an optional second reduced-pressure unit 151). The second
reduced-pressure delivery conduit 156 may be fluidly coupled to the
second reduced-pressure interface 183.
[0042] The reduced-pressure, wound-closure and treatment system 100
is activated such that the first reduced-pressure unit 150 delivers
reduced pressure through the three-way valve 154, which prepares
the second reduced pressure, or treatment reduced pressure, that is
delivered to the first reduced-pressure delivery conduit 142 via
the reduced-pressure conduit 158 and a first reduced pressure, or
closing reduced pressure, that is delivered to the second
reduced-pressure delivery conduit 156. The treatment reduced
pressure delivered through the first reduced-pressure delivery
conduit 142 is realized at the manifold 118, which pulls fluids as
suggested by arrows 144 and 128 and distributes reduced pressure
within the abdominal cavity 110. At the same time, the closing
reduced pressure is delivered through the second reduced-pressure
delivery conduit 156 to the sealed contracting member 188, which
causes the sealed contracting member 188 to contract developing a
closing force, represented by arrows 170, which pulls the first and
second attachment members 172 and 184 towards each other and
thereby the wound edges 112.
[0043] Referring now to FIGS. 3A-3C, a reduced-pressure closure
device 300 for providing a closing force on a surface wound is
presented. The reduced-pressure closure device 300 may be used as
part of a reduced-pressure, wound-closure and treatment system,
like the reduced-pressure, wound-closure and treatment system 100
of FIG. 1 or as a stand alone device. The reduced-pressure closure
device 300 has a plurality of attachment members: a first
attachment member 302, a second attachment member 304, a third
attachment member 306, and a fourth attachment member 308. Each
attachment member 302, 304, 306, 308 has an attachment device for
releasably attaching the attachment member to the patient's
epidermis (or to a sealing member). For example, the first
attachment member 302 includes an adhesive 310 for attaching the
first attachment member 302 to the patient's epidermis and
similarly, the third attachment member 306 has an adhesive 312.
While not shown, the second and fourth attachment members also have
a device, such as an adhesive, for securing the attachment members
to a patient's epidermis. While non-invasive means are generally
considered preferable, it may also be that the attachment members
302, 304, 306, and 308 may be secured using sutures, staples, or
other invasive mechanical means. In addition, other non-invasive
attachment devices may be used, such as cements, bonds, etc.
[0044] A wall 314, which is coupled to the plurality of attachment
members, forms a circumferential wall having an interior space into
which a contracting member 316, or contracting material, is placed.
The sealed contracting member 316 is attached to the wall 314 at
least at points proximate to each attachment member 302, 304, 306,
308. The wall 314 may be made of polypropylene, rigid silicone, or
other semi-rigid material that allows the wall 314 to flex when the
sealed contracting member 316 is contracted. The wall 314 may be
molded, cast, or formed using other techniques. The sealed
contracting member 316 may be made of the same kind of material as
the sealed contracting member 188 in FIG. 1. The sealed contracting
member 316 needs to be sealed and may be sealed by films, layers,
or drapes. The film or other material on the sealed contracting
member 316 may be applied to the first side, or a top side 318 (for
the orientation shown). The sealed contracting member 316 may also
be sealed, at least in part, with the wall 314 covering the
peripheral edge, a sealing member (e.g., sealing member 132 in FIG.
1) providing a seal on the bottom, and a film or drape placed over
the top side 318. A sealant may also be sprayed on to the top side
318 to form a seal. The sealed contracting member 316 may simply be
enveloped in a polyurethane film that has been welded to form an
envelope around the contracting member 316. An opening 320 may be
formed through the sealed contracting member 316. The opening 320
allows for placement of part of a reduced-pressure interface that
extends to a manifold, e.g., the manifold 118 in FIG. 1, below the
reduced-pressure closure device 300. The opening 320 is analogous
to opening 201 in FIG. 1 and is optional depending on desired use.
A reduced-pressure conduit 322 delivers reduced pressure into the
sealed contracting member 316. This may be accomplished by directly
applying the reduced-pressure conduit 322 into any portion of the
sealed contracting member 316, but may also be accomplished using a
reduced-pressure interface 324, e.g., a port, formed on a portion
of the wall 314.
[0045] In operation, the attachment members 302, 304, 306, and 308
are placed around the surface wound and releasably attached to the
epidermis (or sealing member). Opposed attachment members, e.g.,
attachment members 302 and 304, are on opposite sides of the
surface wound. Thus, for example, the first attachment member 302
and the fourth attachment member 308 may each be releasably secured
to one side of a wound at different spaced portions and attachment
members 304 and 306 may each be placed on opposite sides of the
wound. As the reduced-pressure closure device 300 is installed, the
reduced-pressure closure device 300 is initially in a
non-contracted position. Once installed, reduced pressure is
supplied to the reduced-pressure conduit 322 and the sealed
contracting member 316 contracts causing at least portions of the
outer wall 314 to be pulled towards one another and in turn to
develop closing forces that are transmitted between attachment
members, e.g., 302 and 304. Thus, the closing force is developed
and transmitted to the epidermis through the attachment members
302, 304, 306, and 308. FIG. 3B shows the reduced-pressure closure
device 300 in a non-contracted position, and FIG. 3C shows the
reduced-pressure closure device 300 in the contracted position.
[0046] Referring now to FIGS. 4A and 4B, one illustrative
embodiment of a reduced-pressure connector 400 is presented. The
reduced-pressure connector 400 is operable to fluidly connect two
different compartments or areas. In the illustrative embodiment of
FIGS. 4A and 4B, the reduced-pressure connector 400 has a first end
402 and a second end 404. An entry portion 406 is formed on the
second end 404. The entry portion 406 may be shaped as an inverted
conical section to facilitate insertion through various materials,
such as sealing members and manifolds. On the first end 402, a
plurality of flutes 408 may be located to facilitate fluid flow. A
flange portion 410 may be formed between the first end 402 and the
second end 404. The flange portion 410 has a first surface 412 and
a second surface 414. In an alternative embodiment, the first end
402 may also be shaped and configured for easy entry through a
sealing member or other material. Two different, illustrative
applications of the reduced-pressure connector 400 are shown in
FIGS. 5A and 5B.
[0047] Referring to FIG. 5A, a portion of a reduced-pressure,
wound-closure and treatment system 500 is presented. The
reduced-pressure, wound-closure and treatment system 500 is
analogous in most respects to the reduced-pressure, wound-closure
and treatment system 100 of FIG. 1, and to indicate generally
analogous parts, the reference numerals have been indexed by 400. A
manifold 518 is placed within a body cavity, e.g., an abdominal
cavity 510, to help provide reduced-pressure treatment therein. The
manifold 518 is shown proximate to subdermal tissue 514 and a
surface wound 511.
[0048] A sealing member 532 is placed on a patient's epidermis 508
over the abdominal cavity 510 and the surface wound 511. The
surface wound 511 has wound edges 512. The sealing member 532 has
an adhesive 534 helping to form a pneumatic seal with the patient's
epidermis 508. The sealing member 532 as applied forms a pneumatic
seal over the abdominal cavity 510.
[0049] A portion 571 of a wound closure device or subsystem is also
presented. The portion 571 includes a portion of a sealed
contracting member 588. The sealed contracting member 588 is
sealed, at least in part, by a first sealing member 596 and a
second sealing member 598. The sealed contracting member 588 is
attached, at least at certain portions, to the patient's epidermis
508. When reduced pressure is supplied to an interior of the sealed
contracting member 588, the sealed contracting member 588 contracts
and thereby pulls inward and develops a closing force that is
transmitted to the surface wound 511.
[0050] In the illustrative embodiments of FIGS. 5A and 5B, reduced
pressure is supplied by a reduced-pressure source to a
reduced-pressure conduit 542. The reduced-pressure conduit 542 is
fluidly coupled to a reduced-pressure interface 538, which has an
extension portion 602. In the embodiment of FIG. 5A, the extension
portion 602 extends through the sealing member 532 and into the
manifold 518. Thus, reduced pressure is delivered to the manifold
518 and pulls fluids towards the extension portion 602 as suggested
by arrows 544. In this embodiment, the reduced-pressure connector
400 has been added. The reduced-pressure connector 400 is deployed
with the first end 402 within the interior of the sealed
contracting member 588 and the second end 404 within the manifold
518. The reduced-pressure connector 400 thereby fluidly couples the
interior of the sealed contracting member 588 with the manifold
518. Reduced pressure is thereby delivered from the
reduced-pressure interface 538, to the manifold 518, and to the
interior of the sealed contracting member 588. The reduced pressure
delivered through the reduced-pressure connector 400 pulls fluids
within the sealed contracting member 588 as suggested by arrows
545.
[0051] The first surface 412 of the reduced-pressure connector 400
abuts the sealing member 532 and the second surface 414 abuts the
manifold 518. The reduced-pressure connector 400 may be deployed in
numerous ways. For example, with reference to FIGS. 3A and 5A, the
reduced-pressure connector 400 can be placed over a cell, e.g.,
cell 325, of the sealed contracting member 316, and pushed through
the sealing member thereon. The entry portion 406 is shaped to
facilitate such an entry. The sealing member thereon should
self-seal after insertion, but an additional portion of sealing
material could also be added over the insertion point. During
insertion, the reduced-pressure connector 400 is pushed into the
sealed contracting member 316 until the second surface 414 abuts
the second (bottom for orientation shown) sealing member 598 and
the entry portion 406 extends out of the sealed contracting member
316. Referring to now primarily FIG. 5A, the entry portion 406 can
then be inserted through the sealing member 532 and into the
manifold 518. As noted earlier, numerous approaches may be taken
for deploying the reduced-pressure connector 400 and the
reduced-pressure connector 400 may take many different
configurations, but the deployed reduced-pressure connector 400
functionally provides a fluid coupling of the sealed contracting
member 588 and the manifold 518.
[0052] Referring now to FIG. 5B, another alternative is shown. In
the embodiment of FIG. 5B, the extension portion 602 of the
reduced-pressure interface 538 terminates within the sealed
contracting member 588 and delivers reduced pressure within the
sealed contracting member 588. The reduced-pressure connector 400
is deployed in the same manner as previously presented, but now
delivers reduced pressure to the manifold 518. In other words,
fluids are drawn through the manifold 518 through the reduced
pressure connector 400 through an interior of the sealed
contracting member 588 to the extension portion 602 of the
reduced-pressure interface 538 and then through the
reduced-pressure conduit 542.
[0053] Although the present invention and its advantages have been
disclosed in the context of certain illustrative, non-limiting
embodiments, it should be understood that various changes,
substitutions, permutations, and alterations can be made without
departing from the scope of the invention as defined by the
appended claims.
* * * * *